Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
International Journal of Colorectal Disease
Erschienen in: International Journal of Colorectal Disease 12/2011

01.12.2011 | Review

Risk of anastomotic leakage with use of NSAIDs after gastrointestinal surgery

verfasst von: Christian Fredrik Rushfeldt, Baldur Sveinbjørnsson, Kjetil Søreide, Barthold Vonen

Erschienen in: International Journal of Colorectal Disease | Ausgabe 12/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Analgesic regimes to avoid opioid-related adverse effects have been recommended in gastrointestinal surgery. Non-steroidal anti-inflammatory drugs (NSAIDs) are an important component of opioid sparing regimes in that these drugs indirectly reduce pain by inhibiting inflammation. Although beneficial for most surgical patients, animal studies and recent clinical studies suggest a harmful effect on new intestinal anastomoses by increasing the rate of leakage. NSAIDs may indirectly disturb anastomotic healing by inhibiting inflammation as an integrated part of the wound healing process in an early, critical phase after surgery.

Methods

A literature review based on a structured search in PubMed of clinical and experimental studies investigating the effects of NSAIDs on anastomotic healing and leakage rates after intestinal surgery, as well as proposed mechanisms and effects studied in animal models.

Results

Three recent observational cohort studies (accumulated n = 882) indicate an increased rate of anastomotic leakages (15–21%) associated with cyclooxygenase-2 (COX-2) selective NSAIDs after intestinal surgery compared to the leakage rates in controls or historical cohorts (1–4%). Three prospective studies on related topics contain relevant data on NSAIDs and are compared to these studies. Several experimental animal studies support an increased risk for anastomotic leakage with the use of NSAIDs.

Conclusion

The reported effects of NSAIDs on anastomotic healing suggest an increased risk for leakage. A better understanding of the complex interactions of NSAID-induced inhibition on anastomotic healing is a prerequisite for the safe use of NSAIDs. Until more data are available, a careful use of NSAIDs may be warranted in gastrointestinal anastomotic surgery.
Literatur
1.
Pineda CE, Shelton AA, Hernandez-Boussard T et al (2008) Mechanical bowel preparation in intestinal surgery: a meta-analysis and review of the literature. J Gastrointest Surg 12:2037–2044PubMedCrossRef
2.
Shikata S, Yamagishi H, Taji Y et al (2006) Single- versus two-layer intestinal anastomosis: a meta-analysis of randomized controlled trials. BMC Surg 6:2–9PubMedCrossRef
3.
Pickleman J, Watson W, Cunningham J et al (1999) The failed gastrointestinal anastomosis: an inevitable catastrophe? J Am Coll Surg 188:473–482PubMedCrossRef
4.
Golub R, Golub RW, Cantu R et al (1997) A multivariate analysis of factors contributing to leakage of intestinal anastomoses. J Am Coll Surg 184:364–372PubMed
5.
Iancu C, Mocan LC, Todea-Iancu D et al (2008) Host-related predictive factors for anastomotic leakage following large bowel resections for colorectal cancer. J Gastrointestin Liver Dis 17:299–303PubMed
6.
Nandakumar G, Stein SL, Michelassi F (2009) Anastomoses of the lower gastrointestinal tract. Nat Rev Gastroenterol Hepatol 6:709–716PubMedCrossRef
7.
Sørensen LT, Jørgensen T, Kireby LT et al (1999) Smoking and alcohol abuse are major risk factors for anastomotic leakage in colorectal surgery. Br J Surg 86:927–931PubMedCrossRef
8.
Scharfenberg M, Raue W, Junghans T et al (2007) “Fast-track” rehabilitation after colonic surgery in elderly patients — is it feasible? Int J Colorectal Dis 22:1469–1474PubMedCrossRef
9.
Lassen K, Soop M, Nygren J et al (2009) Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations. Arch Surg 144:961–969PubMedCrossRef
10.
Hendry PO, Hausel J, Nygren J et al (2009) Determinants of outcome after colorectal resection within an enhanced recovery programme. Br J Surg 96:197–205PubMedCrossRef
11.
Kehlet H (2005) Postoperative opioid sparing to hasten recovery. Anesthesiology 102:1083–1085PubMedCrossRef
12.
Taylor S, Voytovich AE, Kozol RA (2003) Has the pendulum swung too far in postoperative pain control? Am J Surg 186:472–475PubMedCrossRef
13.
Marret E, Kurdi O, Zufferey P et al (2005) Effects of non-steroidal anti-inflammatory drugs on patient-controlled analgesia morphine side effects: meta-analysis of randomized controlled trials. Anesthesiology 102:1249–1260PubMedCrossRef
14.
Beck A, Krischak G, Sorg T et al (2003) Influence of diclofenac (group of non-steroidal anti-inflammatory drugs) on fracture healing. Arch Orthop Trauma Surg 123:327–332PubMedCrossRef
15.
Boursinos LA, Karachalios T, Poultsides L et al (2009) Do steroids, conventional non-steroidal anti-inflammatory drugs and selective cox-2 inhibitors adversely affect fracture healing? J Muskuloskelet Neuronal Interact 9:44–52
16.
Dodwell ER, Latorre JG, Parisini E et al (2010) NSAID Exposure and Risk of Non-union: A Meta-Analysis of Case-Control and Cohort Studies. Calcif Tissue Int 87:193–202PubMedCrossRef
17.
Levi S, Goodlad RA, Lee CY et al (1990) Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 336:840–843PubMedCrossRef
18.
Ukawa H, Yamakuni H, Kato S et al (1998) Effects of cyclooxygenase-2 selective and nitric oxide-releasing non-steroidal anti-inflammatory drugs on mucosal ulcerogenic and healing responses of the stomach. Dig Dis Sci 43:2003–2011PubMedCrossRef
19.
Sánchez-Fidalgo S, Martín-Lacave I, Illanes M et al (2004) Angiogenesis, cell proliferation and apoptosis in gastric ulcer healing. Effect of a selective cox-2 inhibitor. Eur J Pharmacol 505:187–194PubMedCrossRef
20.
Ofman JJ, MacLean CH, Straus WL et al (2002) A meta-analysis of severe upper gastrointestinal complications of non-steroidal anti-inflammatory drugs. J Rheumatol 29:804–812PubMed
21.
McGettigan P, Henry D (2006) Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and non-selective inhibitors of cyclooxygenase 2. JAMA 296:1633–1644PubMedCrossRef
22.
23.
Warner TD, Mitchell JA (2004) Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 18:790–804PubMedCrossRef
24.
25.
Zimmerman KC, Sarbia M, Schrör K et al (1998) Constitutively cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa. Mol Pharmacol 54:536–540
26.
Rosenberg J, Harvald T (2007) Severe complications with diclofenac after colonic resection. Dis Colon Rectum 50:685PubMedCrossRef
27.
Klein M, Andersen LP, Harvald T et al (2009) Increased risk of anastomotic leakage with diclofenac treatment after laparoscopic colorectal surgery. Dig Surg 26:27–30PubMedCrossRef
28.
Holte K, Andersen J, Jakobsen DH et al (2009) Cyclo-oxygenase 2 inhibitors and the risk of anastomotic leakage after fast-track colonic surgery. Br J Surg 96:650–654PubMedCrossRef
29.
Schlachta CM, Burpee SE, Fernandez C et al (2007) Optimizing recovery after laparoscopic colon surgery (ORAL-CS): effect of intravenous ketorolac on length of hospital stay. Surg Endosc 21:2212–2219PubMedCrossRef
30.
Wattchow DA, De Fontgalland D, Bampton PA et al (2009) Clinical trial: the impact of cyclooxygenase inhibitors on gastrointestinal recovery after major surgery — a randomized double blind clinical trial of celecoxib or diclofenac vs. placebo. Aliment Pharmacol Ther 30:987–998PubMedCrossRef
31.
Vonkemann HE, Fernandes RW, van der Palen J et al (2007) Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study. Nat Clin Pract Rheumatol 3:694–695CrossRef
32.
Neuss H, Raue W, Müller V et al (2009) Effects of cyclooxygenase inhibition on anastomotic healing following large bowel resection in a rabbit model—a randomized, blinded, placebo-controlled trial. Int J Colorectal Dis 24:551–557PubMedCrossRef
33.
Mastboom WJ, Hendriks T, van Elteren P et al (1991) The influence of NSAIDs on experimental intestinal anastomoses. Dis Colon Rectum 34:236–243PubMedCrossRef
34.
De Sousa JB, Soares EG, Aprilli F (1991) Effects of diclofenac sodium on intestinal anastomotic healing. Experimental study on the small intestine of rabbits. Dis Colon Rectum 34:613–617PubMedCrossRef
35.
Cahill RA, Sheehan KM, Scanlon RW et al (2004) Effects of a selective cyclo-oxygenase 2 inhibitor on colonic anastomotic and skin wound integrity. Br J Surg 91:1613–1618PubMedCrossRef
36.
de Hingh IH, van Goor H, de Man BM et al (2006) Selective cyclo-oxygenase 2 inhibition affects ileal but not colonic anastomotic healing in the early postoperative period. Br J Surg 93:489–497PubMedCrossRef
37.
Inan A, Koca C, Sen M (2006) Effects of diclofenac sodium on bursting pressures of anastomoses and hydroxyproline contents of perianastomotic tissues in a laboratory study. Int J Surg 4:222–227PubMedCrossRef
38.
Klein M, Krarup PM, Burcharth J et al (2011) Epub Dec 2010) Effect of diclofenac on cyclooxygenase-2 levels and early breaking strength of experimental colonic anastomoses and skin incisions. Eur Surg Res 46:26–31PubMedCrossRef
39.
Hirasawa N, Ohuchi K, Watanabe M et al (1987) Mechanism of the inhibitory action of cyclooxygenase inhibitors on leukocyte infiltration: involvement of endogenous histamine. Eur J Pharmacol 144:267–275PubMedCrossRef
40.
Menezes GB, Rezende RM, Pereira-Silva PE et al (2008) Differential involvement of cyclooxygenase isoforms in neutrophil migration in vivo and in vitro. Eur J Pharmacol 598:118–122PubMedCrossRef
41.
Ceelen W, El Malt M, Cardon A et al (2001) Influence of preoperative high-dose radiotherapy on postoperative outcome and colonic anastomotic healing: experimental study in the rat. Dis Colon Rectum 44:717–721PubMedCrossRef
42.
Jones MK, Wang H, Peskar BM et al (1999) Inhibition of angiogenesis by non-steroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5:1418–1423PubMedCrossRef
43.
Midwood KS, Williams LV, Schwarzbauer JE (2004) Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 36:1031–1037PubMedCrossRef
44.
Shen W, Prisk V, Li Y et al (2006) Inhibited skeletal muscle healing in cyclooxygenase-2 gene-deficient mice: the role of PGE2 and PGF2alpha. J Appl Physiol 101:1215–1221PubMedCrossRef
45.
Shigeta J, Takahashi S, Okabe S (1998) Role of cyclooxygenase-2 in the healing of gastric ulcers in rats. J Pharmacol Exp Ther 286:1383–1390PubMed
46.
Schmassmann A (1998) Mechanisms of ulcer healing and effects of non-steroidal anti-inflammatory drugs. Am J Med 104:43S–51SPubMedCrossRef
47.
Hatazawa R, Tanigami M, Izumi N et al (2007) Prostaglandin E2 stimulates VEGF expression in primary rat gastric fibroblasts through EP4 receptors. Inflammopharmacology 15:214–217PubMedCrossRef
48.
Gallo O, Franchi A, Magnelli L et al (2001) Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia 3:53–61PubMedCrossRef
49.
Bates DO (2010) Vascular endothelial growth factors and vascular permeability. Cardiovasc Res 87:262–271PubMedCrossRef
50.
Senger DR, Galli SJ, Dvorak AM et al (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983–985PubMedCrossRef
51.
Tomisato W, Tsutsumi S, Rokutan K et al (2001) NSAIDs induce both necrosis and apoptosis in guinea pig gastric mucosal cells in primary culture. Am J Physiol 281:G1092–G1100
52.
Spehlmann ME, Eckmann L (2009) Nuclear factor-kappa b in intestinal protection and destruction. Curr Opin Gastroenterol 25:92–99PubMedCrossRef
53.
Patrono C, Patrignani P, Garcia Rodriguez L (2001) Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J Clin Invest 108:7–13PubMed
54.
Gan TJ (2010) Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin 26:1715–1731PubMedCrossRef
55.
Stamm C, Burkhalter CE, Pearce W et al (1994) Benign colonic ulcers associated with non-steroidal with non-steroidal anti-inflammatory drug ingestion. Am J Gastroenterol 89:2230–2233PubMed
56.
Tomlinson J, Blikslager A (2003) Role of non-steroidal anti-inflammatory drugs in gastrointestinal tract injury and repair. JAVMA 222:946–951PubMedCrossRef
57.
Day JP, Lanas A, Rustagi P et al (1996) Reversible prolonged skin bleeding time in acute gastrointestinal bleeding presumed due to NSAIDs. J Clin Gastroenterol 22:96–103PubMedCrossRef
58.
Crofford LJ, Lipsky PE, Brooks P et al (2000) Basic biology and clinical application of specific cyclooxygenase-2 inhibitors. Arthritis Rheum 43:4–13PubMedCrossRef
59.
Simon LS, Weaver AL, Graham DY et al (1999) Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA 282:1921–1928PubMedCrossRef
60.
Polat A, Nayci A, Polat G et al (2002) Dexamethasone down-regulates endothelial expression of intercellular adhesion molecule and impairs the healing of bowel anastomoses. Eur J Surg 168:500–506PubMedCrossRef
61.
Gürleyik G, Gürleyik E, Yilmazcan A et al (2002) Effects of neurotensin on the healing of experimental anastomosis of the colon. Acta Chir Belg 102:33–36PubMed
62.
Eubanks TR, Greenberg JJ, Dobrin PB et al (1997) The effects of different corticosteroids on the healing colon anastomosis and cecum in a rat model. Am Surg 63:266–269PubMed
63.
Aszodi A, Ponsky JL (1984) Effects of corticosteroid on the healing bowel anastomosis. Am Surg 50:546–548PubMed
64.
Furst MB, Stromberg BV, Blatchford GJ et al (1994) Colonic anastomoses: bursting strength after corticosteroid treatment. Dis Colon Rectum 37:12–15PubMedCrossRef
65.
Wang JJ, Ho ST, Liu YH et al (1999) Dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy. Br J Anaesth 83:772–775PubMed
66.
Block BM, Liu SS, Rowlingson AJ et al (2003) Efficacy of postoperative epidural analgesia. A meta analysis. JAMA 290:2455–2463PubMedCrossRef
Metadaten
Titel
Risk of anastomotic leakage with use of NSAIDs after gastrointestinal surgery
verfasst von
Christian Fredrik Rushfeldt
Baldur Sveinbjørnsson
Kjetil Søreide
Barthold Vonen
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 12/2011
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-011-1285-6

Weitere Artikel der Ausgabe 12/2011

International Journal of Colorectal Disease 12/2011 Zur Ausgabe

Original Article

Sexual and urinary functioning after rectal surgery: a prospective comparative study with a median follow-up of 8.5 years

Original Article

Effectiveness of a drain in surgical treatment of sacrococcygeal pilonidal disease. Results of a randomized and controlled clinical trial on 803 consecutive patients

Original Article

Male sexual dysfunction after rectal cancer surgery

Original Article

Chemokine upregulation in response to anal sphincter and pudendal nerve injury: potential signals for stem cell homing

Letter to the Editor

Colorectal cancer following liver transplantation

Original Article

IL-23/IL-23R: potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.
Bildnachweise